MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX)

Historical Holders from Q1 2014 to Q1 2025

Symbol
MGNX on Nasdaq
CUSIP
556099109
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
62.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
56M
Holdings value
$182M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
125
Number of buys
55
Number of sells
-54
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BB BIOTECH AG 15.8% $12.6M 9.93M BB Biotech AG Dec 31, 2024
ARMISTICE CAPITAL, LLC 9.99% $7.97M 6.28M Armistice Capital, LLC Dec 31, 2024
WASATCH ADVISORS LP 5.6% $4.43M 3.49M WASATCH ADVISORS LP Dec 31, 2024
MILLENNIUM MANAGEMENT LLC 2.7% $2.19M 1.72M Millennium Management LLC Mar 31, 2025

Institutional Holders of MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 206K $260K +$22.4K $1.27 7
2024 Q4 56M $182M +$1.43M $3.25 125
2024 Q3 54.9M $181M -$21.6M $3.29 121
2024 Q2 60.8M $258M -$142M $4.25 141
2024 Q1 64.7M $953M +$51.5M $14.72 159
2023 Q4 61.7M $593M +$41.7M $9.62 134
2023 Q3 58M $270M -$10.6M $4.66 124
2023 Q2 60M $321M +$4.9M $5.35 128
2023 Q1 58.4M $419M +$13.1M $7.17 134
2022 Q4 56.6M $380M +$1.09M $6.71 129
2022 Q3 51.4M $178M -$23.4M $3.46 120
2022 Q2 56.8M $168M -$40M $2.95 118
2022 Q1 59.4M $524M +$331K $8.81 132
2021 Q4 56.8M $912M -$26.5M $16.05 144
2021 Q3 57.1M $1.19B +$1.54M $20.94 146
2021 Q2 56.4M $1.51B -$11.4M $26.86 144
2021 Q1 56M $1.78B +$103M $31.85 167
2020 Q4 52.9M $1.21B -$8.14M $22.86 138
2020 Q3 51.8M $1.31B +$54.4M $25.19 131
2020 Q2 49.8M $1.39B +$299M $27.92 128
2020 Q1 35.9M $209M -$14.1M $5.82 109
2019 Q4 45.3M $493M -$13.7M $10.88 120
2019 Q3 46.4M $592M -$12.4M $12.76 117
2019 Q2 46.9M $796M +$190M $16.97 126
2019 Q1 44M $791M +$150M $17.98 150
2018 Q4 36.7M $466M -$27.6M $12.70 121
2018 Q3 36.8M $789M -$34M $21.44 126
2018 Q2 38.4M $793M +$10M $20.65 124
2018 Q1 37.7M $949M +$110M $25.16 129
2017 Q4 33.6M $638M +$15.1M $19.00 114
2017 Q3 31.5M $582M +$4.95M $18.48 110
2017 Q2 31.2M $546M +$34.4M $17.51 110
2017 Q1 28.8M $536M +$36.8M $18.60 109
2016 Q4 29.1M $594M -$13.8M $20.44 126
2016 Q3 28.1M $840M +$4.83M $29.91 127
2016 Q2 28.1M $759M +$13.5M $26.99 118
2016 Q1 27.9M $523M +$3.76M $18.75 123
2015 Q4 27.6M $855M +$11.8M $30.97 126
2015 Q3 27.1M $581M +$99.9M $21.42 119
2015 Q2 21.5M $816M +$77.7M $37.97 123
2015 Q1 19.8M $620M +$92.8M $31.37 108
2014 Q4 16.8M $589M +$46.5M $35.07 105
2014 Q3 15.4M $322M +$2.19M $20.90 81
2014 Q2 15.3M $332M +$24.1M $21.73 87
2014 Q1 12.5M $348M +$112M $27.83 73